{"data":[{"accessionNo":"0001172661-26-003626","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":3436000,"percentOfClass":5.58,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-26-003626","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":3436000,"percentOfClass":5.58,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-089311","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4442951,"percentOfClass":7.4,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-089311","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4442951,"percentOfClass":7.4,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-089311","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":4442951,"percentOfClass":7.4,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-089311","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":4437293,"percentOfClass":7.3,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-26-002122","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":3500000,"percentOfClass":5.87,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-26-002122","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":3500000,"percentOfClass":5.87,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-26-000263","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-26-000263","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-26-000263","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000102909-26-002679","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics Inc","ticker":"VYGR","cusip":"92915B106","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-26-001298","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":4000000,"percentOfClass":7.19,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-26-001298","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4000000,"percentOfClass":7.19,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-26-000117","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4002847,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-26-000117","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":4002847,"percentOfClass":6.8,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-26-000117","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3756988,"percentOfClass":6.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-006592","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":3407969,"percentOfClass":6.1,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-006592","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3407969,"percentOfClass":6.1,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-006592","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3407969,"percentOfClass":6.1,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001104659-26-006592","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-01-16","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":3338862,"percentOfClass":6,"filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-25-005163","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4200000,"percentOfClass":7.57,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0001172661-25-005163","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":4200000,"percentOfClass":7.57,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-25-000699","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"EcoR1 Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4003636,"percentOfClass":6.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-25-000699","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Oleg Nodelman","reportingCik":null,"personType":"HC,IN","sharesOwned":4003636,"percentOfClass":6.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"},{"accessionNo":"0000935836-25-000699","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001640266","issuerName":"Voyager Therapeutics, Inc.","ticker":"VYGR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"EcoR1 Capital Fund Qualified, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3738856,"percentOfClass":6.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vygr"}],"updatedAt":"2026-11-05T14:36:56.130Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/vygr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}